Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11939346-B2 United States of America 26 Mar 2024
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11851451-B2 United States of America 26 Dec 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11738035-B2 United States of America 29 Aug 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11629159-B2 United States of America 18 Apr 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11564935-B2 United States of America 31 Jan 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11505564-B2 United States of America 22 Nov 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11447510-B2 United States of America 20 Sep 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11180517-B2 United States of America 23 Nov 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11149044-B2 United States of America 19 Oct 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10954259-B1 United States of America 23 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10947257-B2 United States of America 16 Mar 2021
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and… Grant US-8937096-B2 United States of America 20 Jan 2015
Co-therapy for the treatment of epilepsy and related disorders Grant US-8853263-B2 United States of America 07 Oct 2014
USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MANIA AND… Application US-20070155826-A1 United States of America 05 Jul 2007